Recombinant Mouse C-X-C chemokine receptor type 4 (Cxcr4)

What is mouse CXCR4 and what are its primary functions in normal physiology?

Mouse CXCR4 is a seven-transmembrane G-protein-coupled receptor (GPCR) belonging to the CXC chemokine receptor family. It functions primarily as a receptor for the chemokine CXCL12 (also known as SDF-1α). CXCR4 is classified within the superfamily of G-protein-coupled receptors and possesses seven transmembrane helices that transmit signals from CXCL12 to intracellular biological pathways via heterotrimeric G-proteins .

In normal physiology, mouse CXCR4 plays critical roles in multiple processes including embryonic development, hematopoiesis, and immune cell trafficking. It regulates the migration of various cell types including hematopoietic stem cells, neural progenitors, and immune cells. CXCR4 assumes a pivotal role in B-cell development, ranging from early progenitors to the differentiation of antibody-secreting cells . Additionally, it facilitates leukocyte trafficking in lymphoid organs and inflammatory sites through interactions with CXCL12 .

How does mouse CXCR4 compare structurally and functionally to human CXCR4?

Mouse CXCR4 shares high sequence homology and functional similarity with human CXCR4, making mouse models valuable for translational research. Both receptors interact with CXCL12 as their primary ligand and couple to similar G-protein pathways, particularly Gi proteins. Like human CXCR4, mouse CXCR4 is involved in multiple physiological and pathological processes including hematopoiesis, immune responses, and cancer progression .

The structure of mouse CXCR4 closely resembles human CXCR4, with both featuring seven transmembrane domains characteristic of GPCRs, an extracellular N-terminus involved in ligand binding, and an intracellular C-terminus that participates in signaling. The high conservation of structure and function between species supports the use of mouse models for developing and testing CXCR4-targeted therapeutics with potential human applications.

What is the expression pattern of mouse CXCR4 in different tissues?

Mouse CXCR4 is widely expressed across multiple tissues and cell populations. It is predominantly expressed in hematopoietic and immune cells but is also found in neural tissues, heart, and kidney . Within the immune system, CXCR4 is expressed on:

• B cells throughout their developmental stages

• T cells, particularly CD4+ T cells

• Neutrophils and macrophages

• Hematopoietic stem and progenitor cells

In the spleen, CXCR4 is primarily found in CD4+ T cells, while in the liver, it's present in CD3+ T cells and macrophages . This diverse expression pattern reflects the receptor's multiple roles in different biological systems and contributes to its involvement in various physiological and pathological conditions.

What is the primary ligand for mouse CXCR4 and how does this interaction mediate signaling?

The primary ligand for mouse CXCR4 is CXCL12 (SDF-1α). When CXCL12 binds to CXCR4, it triggers conformational changes in the receptor that activate associated heterotrimeric G-proteins, particularly subtypes of the Gi family. Despite CXCR4's ability to form dimers, research has shown that it interacts with CXCL12 in a 1:1 stoichiometry .

The binding initiates various intracellular signaling cascades that regulate cell migration, proliferation, and survival. The CXCL12-CXCR4 signaling axis controls multiple physiological processes including:

• Leukocyte trafficking to lymphoid organs

• Stem cell migration during development and tissue repair

• Cell adhesion and transendothelial migration

• Regulation of tissue homeostasis and organogenesis

These signaling events are tightly regulated and are critical for normal development and immune function in mice.

What are the specifics of CXCR4 signaling mechanisms in mice?

CXCR4 signaling in mice involves several interconnected pathways following activation by CXCL12:

• G-protein coupling preferences:

  • Studies using reconstituted systems have shown that mouse CXCR4 couples most efficiently with Gαi1 and Gαi2

  • Coupling to Gαi3 and Gαo is less efficient but still occurs

• Downstream signaling cascades include:

  • Activation of PI3K/Akt pathway promoting cell survival

  • Stimulation of MAP kinase pathways driving proliferation

  • Regulation of small GTPases controlling cell migration

  • Calcium mobilization affecting various cellular functions

• Regulatory mechanisms:

  • Receptor desensitization through β-arrestin recruitment

  • Internalization following ligand binding

  • Modulation by RGS (Regulator of G-protein Signaling) proteins

Experimental evidence shows that RGS proteins enhance CXCR4-mediated steady-state GTP hydrolysis, indicating that GTP hydrolysis becomes rate-limiting under conditions of agonist stimulation. Additionally, agonist stimulation of GTPase activity is sensitive to monovalent anions, possibly due to increases in G-protein GDP-affinity or interference with ligand/receptor interaction .

How does mouse CXCR4 interact with its ligand CXCL12 at the molecular level?

The molecular interaction between mouse CXCR4 and CXCL12 has been investigated using multiple complementary approaches including structural studies, mutagenesis, and computational modeling:

• Binding stoichiometry and geometry:

  • Despite CXCR4's dimeric nature, it interacts with CXCL12 in a 1:1 stoichiometry

  • The interaction involves two distinct epitopes for recognition

  • Structural modeling informed by cysteine trapping experiments has enabled determination of the receptor:chemokine complex geometry

• Key interaction domains:

  • The N-terminal domain of CXCR4 plays a crucial role in ligand binding

  • Extracellular loops of the receptor form important contacts with CXCL12

  • Specific amino acid residues within these domains create a binding pocket for CXCL12

• Conformational changes:

  • Ligand binding induces structural rearrangements in the transmembrane helices

  • These changes propagate to the intracellular domains to facilitate G-protein coupling

  • Different ligands may induce distinct conformational states leading to biased signaling

This molecular understanding has helped resolve conflicting evidence from earlier structural and mutagenesis studies that suggested several possibilities for receptor:chemokine complex stoichiometry .

What methodologies are available for expressing and purifying recombinant mouse CXCR4?

Expression and purification of recombinant mouse CXCR4 presents several technical challenges due to its nature as a transmembrane protein. Successful methodologies include:

• Expression systems:

  • Baculovirus-infected Sf9 insect cells have proven effective for CXCR4 expression

  • Infection of Sf9 cells with multiple baculoviruses (up to four) encoding different signal transduction proteins is feasible, allowing for systematic analysis of CXCR4/G-protein coupling

  • Mammalian expression systems (HEK293, CHO cells) for studies requiring mammalian post-translational modifications

• Construct design considerations:

  • Addition of affinity tags for purification

  • Inclusion of fusion partners to improve stability

  • Codon optimization for the expression system

• Purification strategies:

  • Careful selection of detergents for membrane extraction

  • Affinity chromatography using tagged constructs

  • Size exclusion chromatography for further purification

• Functional reconstitution:

  • Reconstitution into lipid bilayers or nanodiscs for functional assays

  • Co-expression with G-proteins (particularly Gαi1 and Gαi2, which couple efficiently with CXCR4)

What functional assays are available to study recombinant mouse CXCR4 activity?

Several assays are available to evaluate the functional properties of recombinant mouse CXCR4:

• G-protein activation assays:

  • High-affinity GTPase assay provides an excellent signal-to-noise ratio and constitutes a suitable test system for pharmacological analysis of CXCR4

  • [35S]GTPγS binding assay to detect G-protein activation

  • This approach assesses receptor/G-protein coupling at a proximal level under steady-state conditions without bias from downstream signaling non-linearity

• Receptor binding assays:

  • Saturation binding with labeled ligands to determine affinity constants

  • Competition binding to assess inhibitor potency

  • Kinetic binding studies to determine association/dissociation rates

• Signaling pathway analysis:

  • Measurement of cAMP inhibition (Gi pathway)

  • Calcium mobilization assays

  • ERK phosphorylation assays

  • β-arrestin recruitment assays

• Functional cellular responses:

  • Migration assays (transwell, wound healing)

  • Cell proliferation and survival assays

  • Receptor internalization studies

The high-affinity GTPase assay is particularly valuable as it allows for pharmacological analysis without bias introduced by potential non-linearity of downstream signaling pathways, providing direct measurement of receptor-mediated G-protein activation .

How can computational approaches enhance mouse CXCR4 research?

Computational methods have become invaluable tools for CXCR4 research:

• Molecular modeling and simulations:

  • All-atom molecular dynamics simulations in explicit membrane-water environments provide insights into receptor dynamics and ligand interactions

  • Coarse-grained models allow simulation of larger systems or longer timescales

  • Homology modeling using related receptor structures as templates

• Ligand binding and screening:

  • Virtual screening to identify potential CXCR4-binding molecules

  • Docking studies to predict binding modes and interaction energies

  • Structure-based drug design for optimizing CXCR4 inhibitors

• Applications in structure determination:

  • Model validation through comparison with experimental data

  • Integration with experimental restraints from mutagenesis or crosslinking

  • Refinement of low-resolution structural models

• Case study - EPI-X4 binding mode:

  • Computational approaches helped determine how EPI-X4 (an endogenous peptide antagonist) interacts with CXCR4

  • Multiple binding poses were generated through docking and homology modeling

  • Molecular dynamics simulations in membrane environments refined these models

  • The resulting computational model was validated by mutagenesis and activity studies

These computational approaches provided the foundation for designing shortened EPI-X4 derivatives (7-mers) with optimized receptor antagonizing properties as new leads for CXCR4 inhibitor development .

How can recombinant mouse CXCR4 be used for development and testing of CXCR4-targeted therapeutics?

Recombinant mouse CXCR4 serves as a valuable tool for therapeutic development through several approaches:

• Antagonist screening and development:

  • The GTPase assay system provides an excellent signal-to-noise ratio for testing CXCR4 antagonists

  • This system is valuable for characterizing CXCR4 antagonists with potential applications in treating autoimmune diseases and tumors

  • Structure-based drug design leveraging CXCR4 structural data

  • Optimization of EPI-X4 derivatives (endogenous CXCR4 antagonist)

• Therapeutic targets under investigation:

  • Cancer: Inhibition of metastasis and tumor-stromal interactions

  • Inflammatory diseases: Reduction of pathological immune cell recruitment

  • HIV infection: Blocking of viral entry via CXCR4 co-receptor

  • Stem cell mobilization for transplantation

• Methodological considerations:

  • Parallel testing on mouse and human CXCR4 to assess cross-species activity

  • Reconstituted systems for measuring G-protein activation

  • Cellular assays for downstream signaling events

• Development of EPI-X4 derivatives:

  • EPI-X4, a 16-mer fragment of albumin, is a specific endogenous antagonist and inverse agonist of CXCR4

  • Computational modeling combined with experimental validation has led to shortened 7-mer derivatives with optimized receptor antagonizing properties

  • These derivatives represent promising leads for treating CXCR4-linked disorders such as cancer or inflammatory diseases

The development of CXCR4 inhibitors is particularly important for overcoming viral drug resistance against CCR5 inhibitors in HIV treatment and reducing the occurrence of transitional intermediate variants that can successfully switch to CXCR4-using variants .

What are the challenges in studying mouse CXCR4 in vivo and in vitro?

Research on mouse CXCR4 faces several technical and biological challenges:

• Technical challenges in protein expression and handling:

  • Membrane protein instability outside native environments

  • Difficulty capturing transient receptor states

  • Complexity of reconstituting complete signaling complexes

  • Limited tools for studying native CXCR4 in situ

• Experimental limitations:

  • Potential differences between recombinant systems and native expression

  • Influence of expression system on post-translational modifications

  • Maintaining receptor functionality during purification and reconstitution

  • Accounting for species-specific differences when translating findings

• In vivo challenges:

  • Embryonic lethality of complete CXCR4 knockout necessitating conditional approaches

  • Redundancy in chemokine signaling pathways

  • Contextual differences in CXCR4 function across tissues and developmental stages

  • Technical difficulties in imaging CXCR4-dependent processes in living animals

• Solutions and innovative approaches:

  • Stabilized receptor constructs through protein engineering

  • Advanced membrane mimetics (nanodiscs, lipid cubic phase)

  • Cell-specific conditional knockout/knockin models

  • Complementation strategies for functional studies

For example, functional complementation experiments with multiple pairs of complementary nonfunctional CXCR4 mutants have been used to probe receptor stoichiometry hypotheses, while the strategy of dimer dilution has explored the importance of wild-type CXCR4 dimers .

What are the emerging techniques for studying CXCR4 dynamics and interactions?

Recent technological advances have expanded the toolbox for investigating CXCR4:

• Advanced structural approaches:

  • Cryo-electron microscopy for high-resolution structures

  • Single-particle analysis of receptor complexes

  • Time-resolved structural methods to capture signaling intermediates

• Cutting-edge biophysical methods:

  • Single-molecule tracking of receptor movement in membranes

  • Super-resolution microscopy for visualizing receptor organization

  • Conformational biosensors to monitor receptor activation states

  • Hydrogen-deuterium exchange mass spectrometry for mapping dynamic interactions

• Genome editing technologies:

  • CRISPR/Cas9-mediated generation of specific mutations or variants

  • Knock-in of fluorescent or affinity tags at endogenous loci

  • Site-specific integration of modified CXCR4 variants

• Systems biology approaches:

  • Multi-omics analysis of CXCR4 signaling networks

  • Mathematical modeling of receptor dynamics

  • Integration of computational and experimental datasets

These emerging techniques are providing unprecedented insights into CXCR4 biology and paving the way for more precise therapeutic interventions targeting this receptor.

What are the most promising directions for future CXCR4 research?

Future research on mouse CXCR4 is likely to focus on several promising areas:

• Structural and functional characterization:

  • Higher resolution structures of CXCR4 in complex with diverse ligands

  • Enhanced understanding of the dynamics of receptor activation and signaling

  • Deeper insights into CXCR4 heterodimer formation and functional consequences

• Therapeutic development:

  • Design of biased ligands that selectively activate beneficial pathways

  • Development of tissue-specific CXCR4 modulators

  • Creation of small molecule inhibitors with improved pharmacokinetic properties

  • Optimization of EPI-X4 derivatives as novel therapeutic agents

• Physiological roles:

  • Tissue-specific functions of CXCR4 in development and homeostasis

  • Cell type-specific signaling outcomes and their regulation

  • Context-dependent roles in health and disease

• Translational applications:

  • Improved mouse models for human diseases involving CXCR4

  • Development of imaging agents targeting CXCR4 for diagnostic applications

  • Combinatorial approaches targeting CXCR4 alongside other therapeutic targets

The continued investigation of mouse CXCR4 using integrated experimental and computational approaches will likely yield valuable insights with translational potential for human health and disease.